UROGEN PHARMA LTD.
Source:SEC EDGAR database•Date:March 9, 2017•SIC:2834•CIK:2834
LICENSE AGREEMENT
Source:SEC EDGAR database•Date:December 28, 2016•SIC:2834•CIK:2834
Protagonist Therapeutics, Inc (PTGX) (CIK 0001377121)
Source:SEC EDGAR database•Date:June 22, 2016•SIC:2834•CIK:2834
Erytech Pharma (CIK 0001624422)
Source:SEC EDGAR database•Date:September 8, 2015•SIC:2836•CIK:2836
Erytech Pharma S.A. (CIK 0001624422)
Source:SEC EDGAR database•Date:July 10, 2017•SIC:2836•CIK:2836
BridgeBio Pharma, Inc. (BBIO) (CIK 0001743881)
Source:SEC EDGAR database•Date:May 4, 2023•SIC:2834•CIK:2834
Inozyme Pharma, Inc. (INZY) (CIK 0001693011)
Source:SEC EDGAR database•Date:May 9, 2023•SIC:2834•CIK:2834
Evoke Pharma Inc (EVOK) (CIK 0001403708)
Source:SEC EDGAR database•Date:May 10, 2022•SIC:2834•CIK:2834
Athira Pharma, Inc. (ATHA) (CIK 0001620463)
Source:SEC EDGAR database•Date:March 23, 2023•SIC:2836•CIK:2836
aTYR PHARMA INC (ATYR) (CIK 0001339970)
Source:SEC EDGAR database•Date:February 2, 2015•SIC:2836•CIK:2836